Status:
UNKNOWN
Sex-Informed Data in the COVID-19 Pandemic.
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Covid19
Eligibility:
All Genders
18-100 years
Brief Summary
Sex and gender matter to health equity, especially in a pandemic. Sex (a biological attribute) and gender (a social construct) may influence an individual's susceptibility, vulnerability and exposure ...
Eligibility Criteria
Inclusion
- Patients with laboratory confirmed SARS-Cov-2 infection of any severity.
Exclusion
- Pregnancy.
- Younger than 18 years of age.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04497402
Start Date
September 1 2020
End Date
December 1 2022
Last Update
January 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sapienza University of Rome - Policlinico Umberto I Roma
Rome, Italy, 00166